Published in Diabetes on April 01, 1991
Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol (2009) 4.52
Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int (2010) 2.69
Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med (2006) 2.59
Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest (1997) 2.48
Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest (1993) 2.40
Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology (2011) 2.30
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J (1997) 2.25
Oxidative stress and diabetic retinopathy. Exp Diabetes Res (2007) 2.20
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest (1993) 2.03
Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest (1996) 2.03
Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes (2008) 1.97
Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A (1999) 1.94
Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology (2008) 1.86
Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci U S A (1994) 1.85
The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT). Circ Cardiovasc Qual Outcomes (2013) 1.84
Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction. Am J Physiol Regul Integr Comp Physiol (2010) 1.84
The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol (2010) 1.83
A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci U S A (2002) 1.79
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest (1997) 1.73
Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. Circ Res (2010) 1.73
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci U S A (1994) 1.71
Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. Biochem J (2002) 1.70
Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest (1997) 1.64
Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest (1994) 1.63
Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress. Hypertension (2013) 1.63
Evidence-based Critical Evaluation of Glycemic Potential of Cynodon dactylon. Evid Based Complement Alternat Med (2007) 1.58
Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest (1996) 1.57
How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol (2002) 1.55
The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest (1999) 1.45
Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud (2010) 1.43
Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia (2010) 1.40
Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res (2008) 1.38
Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnology (2010) 1.38
A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC Syst Biol (2011) 1.37
Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev (2008) 1.33
Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest (1994) 1.31
Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease. J Bioenerg Biomembr (2008) 1.31
Ocular complications of diabetes mellitus. World J Diabetes (2015) 1.27
High glucose-induced oxidative stress promotes autophagy through mitochondrial damage in rat notochordal cells. Int Orthop (2013) 1.27
Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy. Diabetes (2008) 1.24
Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes (2012) 1.24
Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon. Br J Pharmacol (1999) 1.24
Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules (2015) 1.23
Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int (2006) 1.23
Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest (1997) 1.22
Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev (2013) 1.21
Protective effects of Annona muricata Linn. (Annonaceae) leaf aqueous extract on serum lipid profiles and oxidative stress in hepatocytes of streptozotocin-treated diabetic rats. Afr J Tradit Complement Altern Med (2008) 1.18
Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension. Clin Exp Pharmacol Physiol (2013) 1.18
Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. J Mol Cell Cardiol (2007) 1.15
Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2. Free Radic Biol Med (2009) 1.15
Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int J Mol Sci (2013) 1.15
Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci U S A (1996) 1.13
Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease. Proc Natl Acad Sci U S A (2008) 1.13
Anti-diabetic, anti-oxidant and anti-hyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin induced diabetic rats. BMC Complement Altern Med (2013) 1.12
Markers of Oxidative Stress during Diabetes Mellitus. J Biomark (2013) 1.12
Diabetes, oxidative stress and physical exercise. J Sports Sci Med (2002) 1.11
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res (2008) 1.10
Oxidative stress in neurodegeneration. Adv Pharmacol Sci (2011) 1.09
Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin J Am Soc Nephrol (2011) 1.09
MicroRNAs: potential mediators and biomarkers of diabetic complications. Free Radic Biol Med (2013) 1.08
Further studies on antioxidant potential and protection of pancreatic beta-cells by Embelia ribes in experimental diabetes. Exp Diabetes Res (2007) 1.08
Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation. Periodontol 2000 (2007) 1.08
Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes. J Clin Invest (1997) 1.07
Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure. Am Heart J (2014) 1.06
Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation. Invest Ophthalmol Vis Sci (2013) 1.05
Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors. Proc Natl Acad Sci U S A (1992) 1.05
Retracted Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation. Diagn Pathol (2013) 1.05
Proinflammatory effects of advanced lipoxidation end products in monocytes. Diabetes (2007) 1.05
Biomedical implications of heavy metals induced imbalances in redox systems. Biomed Res Int (2014) 1.05
Protective effect of saffron extract and crocin on reactive oxygen species-mediated high glucose-induced toxicity in PC12 cells. Cell Mol Neurobiol (2009) 1.04
Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy. Curr Cardiol Rev (2010) 1.03
Absence of a reductase, NCB5OR, causes insulin-deficient diabetes. Proc Natl Acad Sci U S A (2004) 1.03
Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis. Mol Med (2008) 1.03
Antidiabetic properties of germinated brown rice: a systematic review. Evid Based Complement Alternat Med (2012) 1.03
Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes. Free Radic Biol Med (2008) 1.03
Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? Br J Pharmacol (2014) 1.02
Attenuation of oxidative stress in streptozotocin-induced diabetic rats by Eucalyptus globulus. Indian J Clin Biochem (2009) 1.01
Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism. J Ginseng Res (2013) 1.01
Hypoglycaemic, hypolipidemic and antioxidant properties of tulsi (Ocimum sanctum linn) on streptozotocin induced diabetes in rats. Indian J Clin Biochem (2001) 1.01
Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in the kidneys of streptozotocin-induced diabetic rats. Int J Mol Sci (2011) 1.01
Apelin retards the progression of diabetic nephropathy. Am J Physiol Renal Physiol (2013) 1.01
High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling. J Cell Physiol (2012) 1.00
Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J Clin Invest (1995) 1.00
Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. Proc Natl Acad Sci U S A (2005) 1.00
Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdiscip Toxicol (2011) 1.00
Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2. Indian J Clin Biochem (2009) 0.99
Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis. Neurogastroenterol Motil (2014) 0.99
Misincorporation of free m-tyrosine into cellular proteins: a potential cytotoxic mechanism for oxidized amino acids. Biochem J (2006) 0.99
A new automated method for the determination of the Total Antioxidant Capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol (2002) 0.98
Garlic increases antioxidant levels in diabetic and hypertensive rats determined by a modified peroxidase method. Evid Based Complement Alternat Med (2010) 0.98
Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference. Clin Exp Med (2008) 0.98
The As and Ds of stress: metabolic, morphological and behavioral consequences. Eur J Pharmacol (2008) 0.98
Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? Free Radic Biol Med (2013) 0.98
Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes (2015) 0.98
Diabetes and retinal vascular dysfunction. J Ophthalmic Vis Res (2015) 0.98
Preventive effect of Teucrium polium on learning and memory deficits in diabetic rats. Med Sci Monit (2012) 0.97
The Amadori product on protein: structure and reactions. Prog Clin Biol Res (1989) 1.61
Purification of residualizing glycoconjugate labels for protein by reversed-phase high-pressure liquid chromatography. Anal Biochem (1988) 0.82